ABBOTT LABORATORIES 8-K

What Happened

• Abbott Laboratories announced it completed the acquisition of Exact Sciences Corporation under the Agreement and Plan of Merger dated November 19, 2025. The merger closed on March 23, 2026, with Exact surviving as a direct, wholly owned subsidiary of Abbott. At the effective time, each share of Exact Sciences common stock (except certain excluded shares) was converted into the right to receive $105.00 in cash, without interest, less applicable withholding taxes.

Key Details

• Closing date: March 23, 2026 (Effective Time of the merger).
• Purchase price: $105.00 in cash per share of Exact Sciences common stock.
• Structure: Merger Sub merged with and into Exact Sciences; Exact Sciences is now a direct, wholly owned subsidiary of Abbott.
• Documents: The Merger Agreement (dated Nov 19, 2025) is referenced and a press release announcing closing was filed as Exhibit 99.1.

Why It Matters

• The deal immediately integrates Exact Sciences into Abbott and represents a cash acquisition at a fixed per‑share price, which affects Abbott’s cash outflow and adds Exact’s business and assets to Abbott’s portfolio. For investors, the filing confirms the transaction is closed and provides the definitive per‑share consideration and effective date—key facts for assessing impacts on Abbott’s balance sheet, cash position, and strategic exposure to Exact Sciences’ products and revenues.